PLSM
PULSENMORE (PLSM)
NASDAQ
$1.82+$0.05 (+2.94%)
Price as of Oct 23, 2026 7:55 PM EDT
  • $11.0M
    Market Cap
  • N/A
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
Income Statement
Total Operating Revenue
40.0M
N/A
Cost of Revenue
6.3M
N/A
Gross Profit
33.7M
N/A
Sales and Marketing Expense
11.8M
N/A
Research and Development Expense
-17.4M
N/A
Depreciation and Amortization Expense
N/A
N/A
Total Operating Expenses
16.7M
N/A
Operating Profit
N/A
N/A
Interest Income
N/A
N/A
Interest Expense
-7.2M
N/A
Interest Income and Expense and Net
-7.2M
N/A
Total Nonoperating Income and Expense
7.2M
N/A
Income before Taxes
N/A
N/A
Income Taxes
N/A
N/A
Extraordinary Items
N/A
N/A
Net Income
N/A
N/A
Net Income from Continuing Operations Applicable to Common
N/A
N/A
Basic EPS and Net Income
2.46
N/A
Diluted EPS and Net Income
2.46
N/A
Basic Weighted Average Shares
6.4M
N/A
Diluted Weighted Average Shares
6.4M
N/A
Balance Sheet
Cash and Cash Equivalents
21.6M
N/A
Short-Term Investments
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
21.6M
N/A
Total Current Assets
81.4M
N/A
Accumulated Depreciation
N/A
N/A
Property and Plant and Equipment and Net
5.8M
N/A
Total Long-Term Assets
20.4M
N/A
Total Assets
101.8M
N/A
Income Taxes Payable
N/A
N/A
Total Short-Term Debt
N/A
N/A
Total Current Liabilities
10.3M
N/A
Total Long-Term Debt
N/A
N/A
Total Long-Term Liabilities
8.4M
N/A
Total Liabilities
18.8M
N/A
Retained Earnings
-183.1M
N/A
Total Stockholders Equity
83.1M
N/A
Total Shares Outstanding
N/A
N/A
Cash Flow
Cash from Operating Activities
-32.9M
N/A
Capital Expenditures
N/A
N/A
Cash from Investing Activities
13.8M
N/A
Dividends Paid
N/A
N/A
Cash from Financing Activities
4,000
N/A
Financials Ratio
Gross Margin
N/A
N/A
Operating Margin
N/A
N/A
Return on Assets
N/A
N/A
Return on Equity
N/A
N/A
Revenue Growth
N/A
N/A
Current Ratio
N/A
N/A
Cash Ratio
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow